United Arab Emirates
· Delayed Price · Currency is AED JULPHAR Company Description
Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and other pharmaceutical, medical, cosmetic compounds in the United Arab Emirates, other GCC countries, and internationally.
It operates through Manufacturing, Plant, Investment, and Others segment. The company provides generic medicines for pain management, GIT and endocrine, antiviral, respiratory, anti-infectives, cardio care, wound care, dermatology, CNS and psychiatry, biotechnology, gynecology women care, anemia, antibiotics, inflammation, and erectile dysfunction, as well as consumer care products, mouth wash, and vitamins and supplements.
It also offers life products for gastro-intestinal, lifestyle, cough, cold & flu, child and baby care, ophthalmology, and women's health, as well as vitamins and supplements; diabetes solutions including anti diabetes and insulin.
In addition, the company is involved in the provision of transportation, facilities management, health treatment, and hospitals management services; general trading; and retail and wholesale trading of medical equipment and cosmetic products, as well as investment and management of commercial, industrial, and healthcare enterprises.
Gulf Pharmaceutical Industries P.S.C. was incorporated in 1980 and is based in Ras al-Khaimah, the United Arab Emirates.
| Country | United Arab Emirates |
| Founded | 1980 |
| Industry | Pharmaceutical Preparations |
| Employees | 2,400 |
| CEO | Basel Nimer Ziyadeh |
Contact Details
Address: Airport Road Ras al-Khaimah United Arab Emirates | |
| Website | julphar.net |
Stock Details
| Ticker Symbol | JULPHAR |
| Exchange | Abu Dhabi Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AED |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Basel Nimer Ziyadeh | Chief Executive Officer |
| Ignacio Anglada | Chief Financial Officer |